Bio-Rad Laboratories, Inc. Share Price Nyse
Equities
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
279.9 USD | 0.00% | 0.00% | -12.71% |
05-08 | UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating | MT |
05-08 | RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420 | MT |
Sales 2024 * | 2.66B 213B | Sales 2025 * | 2.79B 223B | Capitalization | 8.03B 641B |
---|---|---|---|---|---|
Net income 2024 * | 294M 23.48B | Net income 2025 * | 285M 22.76B | EV / Sales 2024 * | 2.77 x |
Net cash position 2024 * | 674M 53.85B | Net cash position 2025 * | 828M 66.11B | EV / Sales 2025 * | 2.58 x |
P/E ratio 2024 * |
27.4
x | P/E ratio 2025 * |
28.2
x | Employees | 8,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.02% |
Latest transcript on Bio-Rad Laboratories, Inc.
3 months | -14.78% | ||
6 months | -8.79% | ||
Current year | -12.71% |
Managers | Title | Age | Since |
---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 74 | 31/12/88 |
Gregory Hinckley
DFI | Director of Finance/CFO | 77 | 31/01/83 |
Andrew Last
COO | Chief Operating Officer | 64 | 21/04/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Edwards
BRD | Director/Board Member | 64 | 24/04/17 |
Alice Schwartz
FOU | Founder | 97 | 31/12/51 |
Gregory Hinckley
BRD | Director/Board Member | 77 | 24/04/17 |
Date | Price | Change | Volume |
---|---|---|---|
10/05/24 | 279.9 | 0.00% | 0 |
09/05/24 | 279.9 | 0.00% | 0 |
08/05/24 | 279.9 | 0.00% | 0 |
07/05/24 | 279.9 | 0.00% | 0 |
06/05/24 | 279.9 | 0.00% | 0 |
Delayed Quote Nyse, May 10, 2024 at 09:15 pm
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 67.92B | |
+2.39% | 50.96B | |
+9.36% | 44.7B | |
+2.70% | 40.66B | |
+24.51% | 27.6B | |
+3.43% | 26.63B | |
-0.32% | 24.98B |
- Stock Market
- Equities
- BIO Stock
- BIO.B Stock